Odessos Shiprepair Yard S.A. (BUL:ODES)
Bulgaria · Delayed Price · Currency is BGN 330.00
0.00 (0.00%)
At close: Jul 23, 2025
Ligand Pharmaceuticals Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 113.48 | 103.03 | 96.74 | 76.81 | 53.96 | 49.19 | Upgrade |
Other Revenue | 0.27 | 0 | - | - | - | - | Upgrade |
| 113.75 | 103.03 | 96.74 | 76.81 | 53.96 | 49.19 | Upgrade | |
Revenue Growth (YoY) | 11.56% | 6.50% | 25.95% | 42.34% | 9.68% | 24.03% | Upgrade |
Cost of Revenue | 20.89 | 8.35 | 17.43 | 13.44 | 10.83 | 8.27 | Upgrade |
Gross Profit | 92.86 | 94.68 | 79.31 | 63.37 | 43.12 | 40.92 | Upgrade |
Selling, General & Admin | 76.94 | 78.68 | 55.69 | 44.09 | 35.72 | 31.14 | Upgrade |
Other Operating Expenses | 0.35 | 0.2 | 0.24 | -1.87 | -1.05 | -1.22 | Upgrade |
Operating Expenses | 82.87 | 84 | 60.09 | 45.6 | 37.34 | 32.22 | Upgrade |
Operating Income | 9.99 | 10.69 | 19.22 | 17.77 | 5.79 | 8.7 | Upgrade |
Interest Expense | -0.01 | -0.01 | -0.01 | -0.01 | -0 | -0 | Upgrade |
Interest & Investment Income | - | - | - | - | - | 0 | Upgrade |
Currency Exchange Gain (Loss) | -0.19 | 0.03 | -0.05 | 0.02 | 0.04 | -0.03 | Upgrade |
Other Non Operating Income (Expenses) | -0.04 | -0.03 | -0.06 | -0.55 | -0.01 | 0.17 | Upgrade |
EBT Excluding Unusual Items | 9.75 | 10.67 | 19.09 | 17.23 | 5.82 | 8.84 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.11 | -0.08 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | -0 | -0.01 | -0 | Upgrade |
Asset Writedown | -0 | -0 | -0.29 | -0.04 | -0.36 | -0.01 | Upgrade |
Legal Settlements | - | - | - | - | 0.03 | - | Upgrade |
Other Unusual Items | - | - | - | - | 0.08 | 0.06 | Upgrade |
Pretax Income | 9.75 | 10.67 | 18.8 | 17.19 | 5.46 | 8.81 | Upgrade |
Income Tax Expense | 1.07 | 1.07 | 1.88 | 1.78 | 0.58 | 0.88 | Upgrade |
Net Income | 8.68 | 9.6 | 16.92 | 15.41 | 4.88 | 7.93 | Upgrade |
Net Income to Common | 8.68 | 9.6 | 16.92 | 15.41 | 4.88 | 7.93 | Upgrade |
Net Income Growth | -47.61% | -43.26% | 9.81% | 215.57% | -38.44% | 129.88% | Upgrade |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
EPS (Basic) | 14.80 | 16.36 | 28.84 | 26.26 | 8.32 | 13.52 | Upgrade |
EPS (Diluted) | 14.80 | 16.36 | 28.84 | 26.26 | 8.32 | 13.52 | Upgrade |
EPS Growth | -47.61% | -43.26% | 9.81% | 215.57% | -38.44% | 129.88% | Upgrade |
Free Cash Flow | 5.7 | -3.88 | 18.19 | 10.83 | 3.66 | 6.16 | Upgrade |
Free Cash Flow Per Share | 9.72 | -6.62 | 31.00 | 18.45 | 6.23 | 10.50 | Upgrade |
Dividend Per Share | 10.000 | 10.000 | 16.000 | 12.800 | 4.000 | 7.000 | Upgrade |
Dividend Growth | -37.50% | -37.50% | 25.00% | 220.00% | -42.86% | 250.00% | Upgrade |
Gross Margin | 81.64% | 91.90% | 81.98% | 82.51% | 79.92% | 83.18% | Upgrade |
Operating Margin | 8.78% | 10.37% | 19.86% | 23.14% | 10.72% | 17.69% | Upgrade |
Profit Margin | 7.63% | 9.32% | 17.49% | 20.06% | 9.05% | 16.12% | Upgrade |
Free Cash Flow Margin | 5.01% | -3.77% | 18.80% | 14.09% | 6.78% | 12.52% | Upgrade |
EBITDA | 55.91 | 15.84 | 23.38 | 21.14 | 8.42 | 11 | Upgrade |
EBITDA Margin | 49.15% | 15.37% | 24.17% | 27.53% | 15.61% | 22.36% | Upgrade |
D&A For EBITDA | 45.91 | 5.15 | 4.17 | 3.37 | 2.63 | 2.3 | Upgrade |
EBIT | 9.99 | 10.69 | 19.22 | 17.77 | 5.79 | 8.7 | Upgrade |
EBIT Margin | 8.78% | 10.37% | 19.86% | 23.14% | 10.72% | 17.69% | Upgrade |
Effective Tax Rate | 10.97% | 10.03% | 10.01% | 10.36% | 10.65% | 10.00% | Upgrade |
Revenue as Reported | 114.31 | 103.56 | 97.27 | 79.27 | - | - | Upgrade |
Advertising Expenses | - | - | - | - | 0.01 | - | Upgrade |
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.